Monitoring Cord Blood Inventory Reliability By Key Quality Indicators At And After Release

Processes surrounding the implementation of cell therapies require advanced consideration to ensure safety and efficacy. Innovative modalities such as cell therapies are time- and temperature-sensitive, making the packaging of and logistics for materials complex.

As per FACT standards, Cord Blood Banks (CBB) have to verify that they provide a safe and effective product for transplant. Validated processing methods and storage conditions are the first steps towards this goal, but what are the final steps to monitor the quality of the cord blood units (CBU) released for transplant? We present here a retrospective analysis of our Program’s final verification process.